Detection of rare cells in blood and other bodily fluids has numerous important applications including diagnostics, monitoring disease progression and evaluating immune response. For example, detecting and collecting circulating tumour cells (CTCs) in blood can help cancer diagnostics, study their role in the metastatic cascade and predict patient outcomes. However, because each millilitre of whole blood contains billions of blood cells, the rare cells (such as CTCs) that occur at extremely low concentrations (typically lower than 100-1000 cells per millilitre) are very difficult to detect. Although various solutions have been developed to address this challenge, existing techniques in general are limited by high cost and low throughput.
Click here for original story, AI-based cytometer detects rare cells in blood using magnetic modulation and deep learning
Source: Phys.org